SCHEMBL7119944

SCHEMBL7119944

CC(C)(C)OC(=O)NCCc1ccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 7/20 0.55
KMT2A Q03164 6/20 0.55
MEN1 O00255 5/20 0.55
PPARG P37231 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
LMNA P02545 3/20 0.55
MAPT P10636 3/20 0.55
CYP3A4 P08684 2/20 0.55
MAPK1 P28482 2/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
CYP2C19 P33261 1/20 0.55
THPO P40225 1/20 0.55
MTOR P42345 1/20 0.55
PMP22 Q01453 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130748 0.84 KMT2A (0.62) RORCKMT2AMEN1PPARGSMN1; SMN2
SCHEMBL7125255 0.84 RORC (0.62) RORCKMT2AMEN1PPARGSMN1; SMN2
SCHEMBL7119644 0.81 PPARG (0.67) RORCKMT2AMEN1PPARGSMN1; SMN2
SCHEMBL7119725 0.81 MEN1 (0.71) RORCKMT2AMEN1PPARGSMN1; SMN2
SCHEMBL1717941 0.81 MAPT (0.56) KMT2AMEN1PPARGSMN1; SMN2LMNA
SCHEMBL7123352 0.81 KMT2A (0.52) RORCKMT2AMEN1PPARGSMN1; SMN2
SCHEMBL7211781 0.81 NAMPT (0.47) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL7122896 0.80 RORC (0.69) RORCKMT2AMEN1PPARGSMN1; SMN2
SCHEMBL7212951 0.80 NAMPT (0.46) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL7130379 0.80 KMT2A (0.69) RORCKMT2AMEN1PPARGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RORC 67/4885KMT2A 3291/4885MEN1 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.